Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant

Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant

Conditions: Kidney Transplant; Type 1 Diabetes
Interventions: Drug: Alpha 1-Antitrypsin; Procedure: Islet Transplantation; Drug: Thymoglobulin; Drug: Basiliximab; Drug: Etanercept
Sponsors: Massachusetts General Hospital; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Iowa
Completed

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 23, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments